2025 03 18
2025年3月8日，「慶祝三八婦女節、關懷女性健康」公益活動暨「E7蛋白檢測試劑盒全球發表會」在中國香港成功舉辦。本次活動由加拿大遠見控股公司、加拿大陽光關懷慈善基金會、美國Targeted Biotech公司主辦，益奇嘉集團有限公司、加拿大遠見生技集團等協辦。
出席嘉賓包括香港特別行政區議員洪錦賢、簡銘東，陽光關懷慈善基金會主席蔡鳳華，宏信集團董事局主席週帆、董事黃俊，益奇家集團有限公司董事長王莉莉、CEO鐘瑞珍等，以及社會名流百餘人。本次活動也邀請了全球知名健康管理專家王薇博士做女性健康專題講座。宏信控股有限公司現場向陽光關懷慈善基金捐贈了價值23萬港幣的E7蛋白檢測試劑盒，並贈送給在場的所有嘉賓。該產品得到了與會嘉賓的一致好評，稱讚其是香港女性的福音，是早期消滅女性子宮頸癌的最佳選擇。
Visionary Holdings Inc.是美國納斯達克上市公司（股票代碼：GV），為Targeted Biotech USA, Inc.的控股股東。在癌症早期篩檢技術賽道上，敏銳地捕捉了Targeted Biotech USA, Inc.產品的獨特價值和廣闊前景並果斷投入。這不僅為Targeted Biotech USA, Inc.的發展注入了強勁動力，也推動了整個癌症早期篩檢領域的技術創新和產業升級。
陽光關懷慈善基金會是經過香港政府批准成立的公益組織。成立十多年來，為香港社會福利事業發展做出了積極貢獻。從學生的教育資助、青年創業的支持到老年人的關懷，隨處都可以找到陽光心慈善基金會的足跡和聲音。陽光關懷慈善基金會為香港公益事業做出了傑出貢獻。為慶祝2025年三八婦女節，關懷女性，回饋社會，陽光心慈善基金攜手GV舉辦此次守護香港女性健康的公益活動，旨在讓更多香港女性享受健康快樂生活，將子宮頸癌防治工作消滅在萌芽狀態。
本次公益活動以關懷女性健康為核心，致力於推動癌症早期篩檢技術的廣泛普及。在發表會期間，各方就癌症早篩技術推廣應用進行了深入探討，並計劃透過多通路推廣相關產品，協助全球癌症防控，實踐「消滅癌症，從家庭自測開始」的概念。
展望未來，在GV等合作夥伴的大力支持下，Targeted Biotech USA將持續加大研發投入。計畫每年推出5款針對癌症等疾病早期篩檢的居家自我檢測產品，為全球健康事業做出更多貢獻，為企業做出更多貢獻。
Protecting Women's Health: Visionary's Precision Cervical Cancer Screening Public Welfare Activity Brings Health Blessings to Women
On March 8, 2025, the public welfare activity of "Celebrating International Women's Day and Caring for Women's Health" and the "Global Press Conference of E7 Protein Detection Kit" were successfully held in Hong Kong, China. This event was hosted by (Canada) Visionary Holdings Inc., Sun Heart Care Charity Foundation, and Targeted Biotech USA, Inc., and co-organized by Yiqijia Group Co., Ltd. and (Canada) Visionary Biotechnology Group, etc.
The attending guests included Hong Kong Councilors Hung Kam-in and Kan Ming-tung, Chairman of Sun Heart Care Charity Foundation Cai Fenghua, Chairman of the Board of Directors of Visionary Holdings Inc. Zhou Fan and Director Huang Jun, Chairman of Yiqijia Group Co., Ltd. Wang Lili and CEO Zhong Ruizhen, as well as more than 100 social celebrities. The event also invited Dr. Wang Wei, a world-renowned health management expert, to give a special lecture on women's health. Visionary Holdings Inc. donated E7 protein detection kits worth HK$230,000 to Sun Heart Care Charity Foundation on the spot, and also presented them to all the guests present. This product was well received by the attending guests, who praised it as a blessing for women in Hong Kong and the best choice for eliminating cervical cancer in women at an early stage.
Visionary Holdings Inc. is a listed company on the NASDAQ in the United States (stock code: GV) and is the controlling shareholder of Targeted Biotech USA, Inc. GV has always focused on the frontier development in the field of biotechnology, made precise arrangements, and deeply explored technologies and projects with transformative potential. In the track of early cancer screening technology, it keenly captured the unique value and broad prospects of the products of Targeted Biotech USA, Inc. and made a decisive investment. This not only injected strong impetus into the development of Targeted Biotech USA, Inc., but also promoted the technological innovation and industrial upgrading in the entire field of early cancer screening.
Sun Heart Care Charity Foundation is a public welfare organization approved by the Hong Kong government. Since its establishment more than 10 years ago, it has made positive contributions to the development of social welfare undertakings in Hong Kong. From educational support for students, support for youth entrepreneurship to care for the elderly, the footprints and voices of Sun Heart Charity Foundation can be found everywhere. Sun Heart Care Charity Foundation has made outstanding contributions to the public welfare undertakings in Hong Kong. In order to celebrate International Women's Day in 2025, care for women, and give back to the society, Sun Heart Charity Foundation, together with GV, held this public welfare activity to protect the health of women in Hong Kong, aiming to enable more women in Hong Kong to enjoy health and a happy life, and to nip cervical cancer in the bud.